Literature DB >> 11992021

The JT-area indicates dispersion of repolarization in dogs with atrioventricular block.

Jurren M van Opstal1, S Cora Verduyn, Stephan K G Winckels, Hendrik M Leerssen, Jet D M Leunissen, Hein J J Wellens, Marc A Vos.   

Abstract

UNLABELLED: Heterogeneity in cardiac repolarization (Delta APD) is known to be arrhythmic. In the dog model of chronic complete AV-block and acquired long QT syndrome, an increase in Delta MAPD (defined as left ventricular monophasic action potential duration (MAPD) minus right ventricular MAPD) is often associated with changes in T-wave morphology. The purpose of this study was to correlate known changes in Delta MAPD with the planimetric total area of the T-wave on the surface ECG (integral of J-T, mVx ms).
METHODS: The relationship between Delta MAPD and total area of the T-wave (i.e., JT-area) was assessed in four different protocols with different types of dispersion: (1) class III drugs followed by levcromakalim (n= 7), (2) LAD coronary artery occlusion and reperfusion (n = 6), (3) dronedarone i.v., an amiodarone like agent (n = 5) and (4) steady state pacing at cycle lengths of 1000 ms and 500 ms (n = 5).
RESULTS: Class III drugs increased Delta MAPD (55 +/- 40 ms to 120 +/- 50 ms(#), P<0.05), which was correlated (r = 0.74, P < 0.001) with JT-area (50 +/- 40 mV. ms to 95 +/- 35 mV x ms(#)). Ischemia increased both Delta MAPD (30 +/- 25 ms to 90 +/- 40 ms(#)) and JT-area (60 +/- 55 mV x ms to 75 +/- 50 mV x ms(#)). Both levcromakalim and reperfusion reversed these conditions. Dronedarone had no effect on Delta MAPD or on JT-area while a faster frequency reduced both Delta MAPD and JT-area.
CONCLUSION: Changes in dispersion of ventricular repolarization are reflected by alterations in JT-area. This non-invasive parameter may therefore be used to indicate changes in heterogeneity in ventricular repolarization.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11992021     DOI: 10.1023/a:1015302415323

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  38 in total

1.  Comparison of ECG variables of dispersion of ventricular repolarization with direct myocardial repolarization measurements in the human heart.

Authors:  M Zabel; P R Lichtlen; A Haverich; M R Franz
Journal:  J Cardiovasc Electrophysiol       Date:  1998-12

2.  Dispersion of ventricular repolarization: reality? Illusion? Significance?

Authors:  P Coumel; P Maison-Blanche; F Badilini
Journal:  Circulation       Date:  1998-06-30       Impact factor: 29.690

3.  Transmural heterogeneity of ventricular repolarization under baseline and long QT conditions in the canine heart in vivo: torsades de pointes develops with halothane but not pentobarbital anesthesia.

Authors:  J Weissenburger; V V Nesterenko; C Antzelevitch
Journal:  J Cardiovasc Electrophysiol       Date:  2000-03

4.  Electrophysiological effects of dronedarone (SR33589), a noniodinated benzofuran derivative, in the rabbit heart : comparison with amiodarone.

Authors:  W Sun; J S Sarma; B N Singh
Journal:  Circulation       Date:  1999-11-30       Impact factor: 29.690

5.  Role of interventricular dispersion of repolarization in acquired torsade-de-pointes arrhythmias: reversal by magnesium.

Authors:  S C Verduyn; M A Vos; J van der Zande; F F van der Hulst; H J Wellens
Journal:  Cardiovasc Res       Date:  1997-06       Impact factor: 10.787

6.  Notched T waves on Holter recordings enhance detection of patients with LQt2 (HERG) mutations.

Authors:  J M Lupoglazoff; I Denjoy; M Berthet; N Neyroud; L Demay; P Richard; B Hainque; G Vaksmann; D Klug; A Leenhardt; G Maillard; P Coumel; P Guicheney
Journal:  Circulation       Date:  2001-02-27       Impact factor: 29.690

7.  Enhanced susceptibility for acquired torsade de pointes arrhythmias in the dog with chronic, complete AV block is related to cardiac hypertrophy and electrical remodeling.

Authors:  M A Vos; S H de Groot; S C Verduyn; J van der Zande; H D Leunissen; J P Cleutjens; M van Bilsen; M J Daemen; J J Schreuder; M A Allessie; H J Wellens
Journal:  Circulation       Date:  1998-09-15       Impact factor: 29.690

8.  Evaluation of the spatial aspects of T-wave complexity in the long-QT syndrome.

Authors:  S G Priori; D W Mortara; C Napolitano; L Diehl; V Paganini; F Cantù; G Cantù; P J Schwartz
Journal:  Circulation       Date:  1997-11-04       Impact factor: 29.690

9.  Long QT syndrome. New electrocardiographic characteristics.

Authors:  J Benhorin; M Merri; M Alberti; E Locati; A J Moss; W J Hall; L Cui
Journal:  Circulation       Date:  1990-08       Impact factor: 29.690

10.  QTU prolongation and polymorphic ventricular tachyarrhythmias due to bradycardia-dependent early afterdepolarizations. Afterdepolarizations and ventricular arrhythmias.

Authors:  N el-Sherif; R H Zeiler; W Craelius; W B Gough; R Henkin
Journal:  Circ Res       Date:  1988-08       Impact factor: 17.367

View more
  5 in total

1.  Torsadogenic Drug-induced Increased Short-term Variability of JT-area.

Authors:  Xiao Jie; Blanca Rodriguez; Esther Pueyo
Journal:  Comput Cardiol (2010)       Date:  2010-09-26

2.  A new ECG biomarker for drug toxicity: a combined signal processing and computational modeling study.

Authors:  Xiao Jie; Blanca Rodriguez; Esther Pueyo
Journal:  Annu Int Conf IEEE Eng Med Biol Soc       Date:  2010

3.  Einthoven Dissertation Prizes 2002.

Authors: 
Journal:  Neth Heart J       Date:  2003-04       Impact factor: 2.380

4.  Effect of heart rate on ventricular repolarization in healthy individuals applying vectorcardiographic T vector and T vector loop analysis.

Authors:  Farzad Vahedi; Michael F Haney; Steen M Jensen; Ulf Näslund; Lennart Bergfeldt
Journal:  Ann Noninvasive Electrocardiol       Date:  2011-07       Impact factor: 1.468

Review 5.  Arrhythmic risk biomarkers for the assessment of drug cardiotoxicity: from experiments to computer simulations.

Authors:  A Corrias; X Jie; L Romero; M J Bishop; M Bernabeu; E Pueyo; B Rodriguez
Journal:  Philos Trans A Math Phys Eng Sci       Date:  2010-06-28       Impact factor: 4.226

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.